Description: Cardio Diagnostics is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. Cardio was formed to further develop and commercialize a proprietary Artificial Intelligence (AI)-driven Integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become one of the leading medical technology companies for enabling improved prevention, early detection, and assists in treatment of cardiovascular disease.
Home Page: cardiodiagnosticsinc.com
CDIO Technical Analysis
311 West Superior Street
Chicago,
IL
60654
United States
Phone:
302 281 2147
Officers
| Name | Title |
|---|---|
| Dr. Meeshanthini V. Dogan Ph.D. | Co-Founder, CEO & Director |
| Ms. Elisa Michael Luqman Esq., J.D., M.B.A. | Chief Financial Officer |
| Dr. Robert A. Philibert M.D., Ph.D. | Co-Founder, Chief Medical Officer & Director |
| Mr. Timur Dogan Ph.D. | Chief Technology Officer |
| Ms. Khullani Abdullahi J.D. | Vice President of Revenue & Strategy |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 13.1648 |
| Price-to-Sales TTM: | 1570.5597 |
| IPO Date: | 2022-01-14 |
| Fiscal Year End: | December |
| Full Time Employees: | 7 |